Solara Active Pharma Sciences Ltd
NSE:SOLARA

Watchlist Manager
Solara Active Pharma Sciences Ltd Logo
Solara Active Pharma Sciences Ltd
NSE:SOLARA
Watchlist
Price: 660.25 INR 0.14% Market Closed
Market Cap: 31.7B INR
Have any thoughts about
Solara Active Pharma Sciences Ltd?
Write Note

Relative Value

The Relative Value of one SOLARA stock under the Base Case scenario is 714.53 INR. Compared to the current market price of 660.25 INR, Solara Active Pharma Sciences Ltd is Undervalued by 8%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

SOLARA Relative Value
Base Case
714.53 INR
Undervaluation 8%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
28
vs Industry
50
Median 3Y
1.6
Median 5Y
2.1
Industry
2.5
Forward
2
vs History
vs Industry
Median 3Y
-14.9
Median 5Y
-5.6
Industry
21.8
Forward
29.4
vs History
9
vs Industry
17
Median 3Y
10.8
Median 5Y
11.4
Industry
16.1
vs History
vs Industry
0
Median 3Y
-35.7
Median 5Y
-38.1
Industry
23.8
vs History
22
vs Industry
26
Median 3Y
1.4
Median 5Y
2.2
Industry
2.1
vs History
30
vs Industry
47
Median 3Y
2.1
Median 5Y
2.4
Industry
2.7
Forward
2.1
vs History
12
vs Industry
36
Median 3Y
5.2
Median 5Y
5.6
Industry
5.2
vs History
vs Industry
30
Median 3Y
12.9
Median 5Y
15.1
Industry
13.5
Forward
11.6
vs History
vs Industry
9
Median 3Y
-14
Median 5Y
18.9
Industry
16.8
Forward
20.1
vs History
9
vs Industry
17
Median 3Y
11.9
Median 5Y
12.6
Industry
15.2
vs History
17
vs Industry
11
Median 3Y
31.1
Median 5Y
-6.6
Industry
19.3
vs History
30
vs Industry
47
Median 3Y
1
Median 5Y
1.5
Industry
1.9

Multiples Across Competitors

SOLARA Competitors Multiples
Solara Active Pharma Sciences Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
IN
Solara Active Pharma Sciences Ltd
NSE:SOLARA
31.7B INR 2.6 -5.9 -66.7 -21.6
JP
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
776 550.9T JPY 4 211 733 -5 347 888.9 -5 459 134.4 -5 046 864.6
US
Eli Lilly and Co
NYSE:LLY
755.8B USD 18.5 90.3 48.5 54.1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP 578.3 -15 783.5 3 846.3 17 702.3
DK
Novo Nordisk A/S
CSE:NOVO B
2.7T DKK 10.2 29 20.2 23
US
Johnson & Johnson
NYSE:JNJ
351.1B USD 4 23.9 11.6 15.1
US
Merck & Co Inc
NYSE:MRK
251.8B USD 4 20.7 10.5 12.5
CH
Roche Holding AG
SIX:ROG
200.1B CHF 3.4 17.4 9.8 11.6
UK
AstraZeneca PLC
LSE:AZN
161.8B GBP 4.1 31.5 169.4 253.8
CH
Novartis AG
SIX:NOVN
171.5B CHF 3.8 10.8 9.4 13.1
US
Pfizer Inc
NYSE:PFE
151.5B USD 2.5 35.6 10.6 16
P/E Multiple
Earnings Growth P/E to Growth
IN
Solara Active Pharma Sciences Ltd
NSE:SOLARA
Average P/E: 32.4
Negative Multiple: -5.9
N/A N/A
JP
N
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
Negative Multiple: -5 347 888.9 N/A N/A
US
Eli Lilly and Co
NYSE:LLY
90.3
446%
0.2
UK
Dechra Pharmaceuticals PLC
LSE:DPH
Negative Multiple: -15 783.5 N/A N/A
DK
Novo Nordisk A/S
CSE:NOVO B
29
86%
0.3
US
Johnson & Johnson
NYSE:JNJ
23.9
-23%
N/A
US
Merck & Co Inc
NYSE:MRK
20.7
7 300%
0
CH
Roche Holding AG
SIX:ROG
17.4
54%
0.3
UK
AstraZeneca PLC
LSE:AZN
31.5
177%
0.2
CH
Novartis AG
SIX:NOVN
10.8
31%
0.3
US
Pfizer Inc
NYSE:PFE
35.6
719%
0
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
IN
Solara Active Pharma Sciences Ltd
NSE:SOLARA
Average EV/EBITDA: 459.6
Negative Multiple: -66.7
N/A N/A
JP
N
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
Negative Multiple: -5 459 134.4 N/A N/A
US
Eli Lilly and Co
NYSE:LLY
48.5
195%
0.2
UK
Dechra Pharmaceuticals PLC
LSE:DPH
3 846.3
151%
25.5
DK
Novo Nordisk A/S
CSE:NOVO B
20.2
84%
0.2
US
Johnson & Johnson
NYSE:JNJ
11.6
14%
0.8
US
Merck & Co Inc
NYSE:MRK
10.5
331%
0
CH
Roche Holding AG
SIX:ROG
9.8
23%
0.4
UK
AstraZeneca PLC
LSE:AZN
169.4
64%
2.7
CH
Novartis AG
SIX:NOVN
9.4
8%
1.2
US
Pfizer Inc
NYSE:PFE
10.6
31%
0.3
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
IN
Solara Active Pharma Sciences Ltd
NSE:SOLARA
Average EV/EBIT: 2 011.3
Negative Multiple: -21.6
N/A N/A
JP
N
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
Negative Multiple: -5 046 864.6 N/A N/A
US
Eli Lilly and Co
NYSE:LLY
54.1
211%
0.3
UK
Dechra Pharmaceuticals PLC
LSE:DPH
17 702.3
675%
26.2
DK
Novo Nordisk A/S
CSE:NOVO B
23
83%
0.3
US
Johnson & Johnson
NYSE:JNJ
15.1
28%
0.5
US
Merck & Co Inc
NYSE:MRK
12.5
675%
0
CH
Roche Holding AG
SIX:ROG
11.6
28%
0.4
UK
AstraZeneca PLC
LSE:AZN
253.8
131%
1.9
CH
Novartis AG
SIX:NOVN
13.1
58%
0.2
US
Pfizer Inc
NYSE:PFE
16
68%
0.2

See Also

Discover More
Back to Top